Trials / Completed
CompletedNCT02830282
Surveillance Markers of Utility for Recurrence After Neoadjuvant Chemotherapy for Breast Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 21 (actual)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a nested multicenter, prospective cohort study within the I-SPY 2 TRIAL for women undergoing neoadjuvant chemotherapy for primary breast cancer who are also undergoing definitive surgical resection and have clinical or radiographic evidence of residual tumor at the completion of chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood Collection |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2018-03-16
- Completion
- 2018-03-16
- First posted
- 2016-07-12
- Last updated
- 2020-02-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02830282. Inclusion in this directory is not an endorsement.